Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BillionToOne, Inc. (BLLN)
USD123.38
+0.13 (+0.11%)
US NASDAQ Healthcare Medical - Diagnostics & Research
Address
1035 O’Brien Drive 94025
Menlo Park, CA, US
Menlo Park, CA, US
CEO
Oguzhan Atay
Website
billiontoone.com
IPO
2025-11-06
CIK 2070849 ISIN US0901681058
Description
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD123.38
+0.13 (+0.11%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
680.6K
Beta
0.47
Float Shares
5.46M
Free Float %
11.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -11.05% | +15.48% | +16.15% | +5.06% | -7.44% | +15.14% | -13.50% | -13.50% | -13.50% | -13.50% | -13.50% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
123.38
Low
110.00
-10.8%
Consensus
128.67
+4.3%
Median
125.00
+1.3%
High
150.00
+21.6%
DCF (Unlevered)
2,200.03
+1,683.1%
DCF (Levered)
2,126.68
+1,623.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 4 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
130.00
+5.4%
|
| Last Quarter | 2 |
135.00
+9.4%
|
| Last Year | 8 |
134.00
+8.6%
|
| All Time | 8 |
134.00
+8.6%
|
Quality scores
Altman Z-Score
14.45
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
5 / 10
Developing
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Diagnostics & Research: +7.9%+100.0% ★ Q1'26: +83.8% (vs Q1'25)
-
EPS growth Medical - Diagnostics & Research: +30.8%+106.9% ★ Q1'26: +481.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Diagnostics & Research: +32.2%-2.1% Q1'26: +10.1% (vs Q1'25)
-
EBIT margin Medical - Diagnostics & Research: +9.6%+5.3% Q1'26: +16.5% (vs Q1'25)
-
ROIC Medical - Diagnostics & Research: +5.2%+16.6% ★ Q1'26: +61.6% (vs Q1'25)
-
Share dilution Medical - Diagnostics & Research: 0.0%+2.4% Q1'26: +18.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Diagnostics & Research: -0.13×6.80× ★ Q1'26: 1.73× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 6 Rev. Ana. 3 EPS Ana. |
Dec 2027 6 Rev. Ana. 4 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
152.58M
est: 209.03M (-27.0%)
|
305.11M
est: 296.23M (+3.0%)
|
454.29M
444.26M – 464.31M
+53.4% YoY
|
580.27M
566.09M – 594.34M
+27.7% YoY
|
727.93M
726.31M – 729.55M
+25.4% YoY
|
790.15M
765.39M – 813.89M
+8.5% YoY
|
834.00M
807.87M – 859.06M
+5.5% YoY
|
| EBITDA |
-27.47M
est: 179.07M (-115.3%)
|
16.02M
est: 253.77M (-93.7%)
|
389.18M
380.59M – 397.76M
+53.4% YoY
|
497.11M
484.96M – 509.16M
+27.7% YoY
|
623.60M
622.22M – 624.99M
+25.4% YoY
|
676.91M
655.69M – 697.25M
+8.5% YoY
|
714.47M
692.08M – 735.94M
+5.5% YoY
|
| EBIT |
-39.16M
est: 182.17M (-121.5%)
|
16.02M
est: 258.17M (-93.8%)
|
395.92M
387.18M – 404.65M
+53.4% YoY
|
505.72M
493.35M – 517.98M
+27.7% YoY
|
634.40M
632.99M – 635.81M
+25.4% YoY
|
688.63M
667.05M – 709.32M
+8.5% YoY
|
726.84M
704.07M – 748.68M
+5.5% YoY
|
| Net Income |
-41.57M
est: -136.77M (+69.6%)
|
7.45M
est: 4.65M (+60.3%)
|
37.93M
25.69M – 50.16M
+715.9% YoY
|
54.02M
45.01M – 63.02M
+42.4% YoY
|
107.66M
50.85M – 125.07M
+99.3% YoY
|
117.03M
112.26M – 121.60M
+8.7% YoY
|
75.12M
72.06M – 78.05M
-35.8% YoY
|
| SGA |
91.47M
est: 136.98M (-33.2%)
|
143.05M
est: 194.13M (-26.3%)
|
297.70M
291.13M – 304.27M
+53.4% YoY
|
380.27M
370.97M – 389.49M
+27.7% YoY
|
477.03M
475.97M – 478.09M
+25.4% YoY
|
517.80M
501.58M – 533.36M
+8.5% YoY
|
546.54M
529.41M – 562.96M
+5.5% YoY
|
| EPS |
-0.93
est: -2.99 (+68.9%)
|
0.06
est: 0.11 (-40.7%)
|
0.84
0.56 – 1.10
+683.0% YoY
|
1.14
0.98 – 1.38
+35.1% YoY
|
1.96
1.11 – 2.73
+72.7% YoY
|
2.56
2.45 – 2.65
+30.1% YoY
|
1.64
1.57 – 1.70
-35.8% YoY
|
Recent Grade Changes (3M)
| Date | Firm | Previous | New Grade | Action |
|---|---|---|---|---|
| 2026-05-07 | BTIG | Buy | Buy | Maintain |
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B- | 3/5 | 4/5 | 3/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 2/5 | 3/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | B- | 2/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | B- | 2/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | B- | 2/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | B- | 2/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | B- | 2/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | B- | 2/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C+ | 2/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
85.75M
OE per share TTM
1.79
Owner's Yield
2.01%
Maintenance CapEx ratio
84.12%
Maint CapEx / Avg PPE
39.6%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
7
Total invested
29.96M
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
7
-82 vs prev Q
New positions
4
Closed positions
86
Increased
5
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ADAMS STREET PARTNERS LLC | 1.71M +1.7M (+100.0%) | 140.06M +140.1M (+100.0%) | 3.83% +3.827 pp | 53.07% +53.072 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 2 | BAILLIE GIFFORD & CO | 1.27M +1.3M (+100.0%) | 103.79M +103.8M (+100.0%) | 2.84% +2.836 pp | 0.09% +0.086 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 3 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 1.0K +1.0K (+100.0%) | 81.84M +81.8M (+100.0%) | 0.00% +0.002 pp | 0.07% +0.070 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 4 | NEUBERGER BERMAN GROUP LLC | 700.9K +700.9K (+100.0%) | 57.36M +57.4M (+100.0%) | 1.57% +1.567 pp | 0.04% +0.043 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 5 | NVP ASSOCIATES, LLC | 513.3K +513.3K (+100.0%) | 42.01M +42.0M (+100.0%) | 1.15% +1.148 pp | 16.46% +16.461 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 6 | PRICE T ROWE ASSOCIATES INC /MD/ | 485.3K +485.3K (+100.0%) | 39.72M +39.7M (+100.0%) | 1.09% +1.085 pp | 0.00% +0.004 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 7 | JPMORGAN CHASE & CO | 392.0K +392.0K (+100.0%) | 32.08M +32.1M (+100.0%) | 0.88% +0.877 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 8 | VANGUARD GROUP INC | 352.4K +352.4K (+100.0%) | 28.84M +28.8M (+100.0%) | 0.79% +0.788 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 9 | NAPEAN TRADING & INVESTMENT CO (SINGAPORE) PTE LTD | 233.3K +233.3K (+100.0%) | 19.10M +19.1M (+100.0%) | 0.52% +0.522 pp | 3.71% +3.715 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 10 | UBS ASSET MANAGEMENT AMERICAS INC | 227.7K +227.7K (+100.0%) | 18.63M +18.6M (+100.0%) | 0.51% +0.509 pp | 0.00% +0.004 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 11 | ALLIANCEBERNSTEIN L.P. | 208.6K +208.6K (+100.0%) | 17.07M +17.1M (+100.0%) | 0.47% +0.466 pp | 0.01% +0.005 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 12 | INVESCO LTD. | 189.8K +189.8K (+100.0%) | 15.53M +15.5M (+100.0%) | 0.42% +0.425 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 13 | EMERALD ADVISERS, LLC | 188.9K +188.9K (+100.0%) | 15.46M +15.5M (+100.0%) | 0.42% +0.423 pp | 0.48% +0.476 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 14 | CAPITAL INTERNATIONAL INVESTORS | 178.0K +178.0K (+100.0%) | 14.57M +14.6M (+100.0%) | 0.40% +0.398 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 15 | BAMCO INC /NY/ | 170.0K +170.0K (+100.0%) | 13.91M +13.9M (+100.0%) | 0.38% +0.380 pp | 0.04% +0.038 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 16 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 163.4K +163.4K (+100.0%) | 13.37M +13.4M (+100.0%) | 0.37% +0.365 pp | 0.00% +0.004 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 17 | CITADEL ADVISORS LLC | 148.9K +148.9K (+100.0%) | 12.18M +12.2M (+100.0%) | 0.33% +0.333 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 18 | AMERIPRISE FINANCIAL INC | 122.3K +122.3K (+100.0%) | 10.01M +10.0M (+100.0%) | 0.27% +0.273 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 19 | EMERALD MUTUAL FUND ADVISERS TRUST | 118.1K +118.1K (+100.0%) | 9.67M +9.7M (+100.0%) | 0.26% +0.264 pp | 0.47% +0.471 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 20 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 101.1K +101.1K (+100.0%) | 8.28M +8.3M (+100.0%) | 0.23% +0.226 pp | 0.01% +0.005 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 21 | PFM HEALTH SCIENCES, LP | 87.5K +87.5K (+100.0%) | 7.16M +7.2M (+100.0%) | 0.20% +0.196 pp | 0.71% +0.714 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 22 | SIREN, L.L.C. | 83.8K +83.8K (+100.0%) | 6.86M +6.9M (+100.0%) | 0.19% +0.188 pp | 0.20% +0.205 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 23 | GEODE CAPITAL MANAGEMENT, LLC | 82.0K +82.0K (+100.0%) | 6.72M +6.7M (+100.0%) | 0.18% +0.183 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 24 | PERCEPTIVE ADVISORS LLC | 72.8K +72.8K (+100.0%) | 5.96M +6.0M (+100.0%) | 0.16% +0.163 pp | 0.11% +0.106 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 25 | BLACKROCK, INC. | 71.4K +71.4K (+100.0%) | 5.84M +5.8M (+100.0%) | 0.16% +0.160 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 26 | BRAIDWELL LP | 50.0K +50.0K (+100.0%) | 4.09M +4.1M (+100.0%) | 0.11% +0.112 pp | 0.13% +0.131 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 27 | DEEP TRACK CAPITAL, LP | 50.0K +50.0K (+100.0%) | 4.09M +4.1M (+100.0%) | 0.11% +0.112 pp | 0.07% +0.073 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 28 | LORD, ABBETT & CO. LLC | 46.3K +46.3K (+100.0%) | 3.79M +3.8M (+100.0%) | 0.10% +0.104 pp | 0.01% +0.012 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 29 | MYDA ADVISORS LLC | 40.2K +40.2K (+100.0%) | 3.29M +3.3M (+100.0%) | 0.09% +0.090 pp | 0.63% +0.627 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 30 | NEXT CENTURY GROWTH INVESTORS LLC | 36.7K +36.7K (+100.0%) | 3.00M +3.0M (+100.0%) | 0.08% +0.082 pp | 0.21% +0.208 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 31 | VERITION FUND MANAGEMENT LLC | 33.3K +33.3K (+100.0%) | 2.73M +2.7M (+100.0%) | 0.07% +0.075 pp | 0.01% +0.011 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 32 | UBS GROUP AG | 31.6K +31.6K (+100.0%) | 2.59M +2.6M (+100.0%) | 0.07% +0.071 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 33 | TD ASSET MANAGEMENT INC | 26.7K +26.7K (+100.0%) | 2.19M +2.2M (+100.0%) | 0.06% +0.060 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 34 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 26.6K +26.6K (+100.0%) | 2.18M +2.2M (+100.0%) | 0.06% +0.060 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 35 | CATALIO CAPITAL MANAGEMENT, LP | 25.5K +25.5K (+100.0%) | 2.09M +2.1M (+100.0%) | 0.06% +0.057 pp | 0.37% +0.369 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 36 | SEVEN GRAND MANAGERS, LLC | 25.0K +25.0K (+100.0%) | 2.05M +2.0M (+100.0%) | 0.06% +0.056 pp | 0.16% +0.156 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 37 | STATE STREET CORP | 21.6K +21.6K (+100.0%) | 1.77M +1.8M (+100.0%) | 0.05% +0.048 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 38 | MARSHALL WACE, LLP | 20.9K +20.9K (+100.0%) | 1.71M +1.7M (+100.0%) | 0.05% +0.047 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 39 | GOLDMAN SACHS GROUP INC | 20.7K +20.7K (+100.0%) | 1.70M +1.7M (+100.0%) | 0.05% +0.046 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 40 | XTX TOPCO LTD | 20.7K +20.7K (+100.0%) | 1.69M +1.7M (+100.0%) | 0.05% +0.046 pp | 0.04% +0.044 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 41 | SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 19.8K +19.8K (+100.0%) | 1.62M +1.6M (+100.0%) | 0.04% +0.044 pp | 0.03% +0.034 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 42 | WOODLINE PARTNERS LP | 17.0K +17.0K (+100.0%) | 1.39M +1.4M (+100.0%) | 0.04% +0.038 pp | 0.01% +0.005 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 43 | UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 16.5K +16.5K (+100.0%) | 1.35M +1.3M (+100.0%) | 0.04% +0.037 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 44 | SOROS FUND MANAGEMENT LLC | 14.5K +14.5K (+100.0%) | 1.19M +1.2M (+100.0%) | 0.03% +0.032 pp | 0.01% +0.014 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 45 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 12.1K +12.1K (+100.0%) | 1.03M +1.0M (+100.0%) | 0.03% +0.027 pp | 0.00% +0.001 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 46 | BELLEVUE GROUP AG | 10.6K +10.6K (+100.0%) | 866.6K +866.6K (+100.0%) | 0.02% +0.024 pp | 0.02% +0.016 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 47 | NORGES BANK | 10.0K +10.0K (+100.0%) | 818.4K +818.4K (+100.0%) | 0.02% +0.022 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 48 | SQUAREPOINT OPS LLC | 7.9K +7.9K (+100.0%) | 645.8K +645.8K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.001 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 49 | QUADRATURE CAPITAL LTD | 7.5K +7.5K (+100.0%) | 613.7K +613.7K (+100.0%) | 0.02% +0.017 pp | 0.01% +0.006 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 50 | GHISALLO CAPITAL MANAGEMENT LLC | 7.0K +7.0K (+100.0%) | 572.9K +572.9K (+100.0%) | 0.02% +0.016 pp | 0.03% +0.026 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 51 | ALYESKA INVESTMENT GROUP, L.P. | 7.0K +7.0K (+100.0%) | 572.9K +572.9K (+100.0%) | 0.02% +0.016 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 52 | FNY INVESTMENT ADVISERS, LLC | 6.1K +6.1K (+100.0%) | 497.0K +497.0K (+100.0%) | 0.01% +0.014 pp | 0.14% +0.140 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 53 | WALLEYE CAPITAL LLC | 6.0K +6.0K (+100.0%) | 487.8K +487.8K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 54 | ENGINEERS GATE MANAGER LP | 5.8K +5.8K (+100.0%) | 477.0K +477.0K (+100.0%) | 0.01% +0.013 pp | 0.01% +0.006 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 55 | MILLENNIUM MANAGEMENT LLC | 5.7K +5.7K (+100.0%) | 467.0K +467.0K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 56 | ROYAL BANK OF CANADA | 5.6K +5.6K (+100.0%) | 456.0K +456.0K (+100.0%) | 0.01% +0.013 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 57 | GREEN ALPHA ADVISORS, LLC | 5.3K +5.3K (+100.0%) | 435.9K +435.9K (+100.0%) | 0.01% +0.012 pp | 0.40% +0.399 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 58 | NEW YORK STATE COMMON RETIREMENT FUND | 5.1K +5.1K (+100.0%) | 418.8K +418.8K (+100.0%) | 0.01% +0.011 pp | 0.00% +0.001 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 59 | SIGMA PLANNING CORP | 5.0K +5.0K (+100.0%) | 409.2K +409.2K (+100.0%) | 0.01% +0.011 pp | 0.01% +0.011 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 60 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 4.6K +4.6K (+100.0%) | 394.0K +394.0K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.004 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 61 | PATHSTONE HOLDINGS, LLC | 4.3K +4.3K (+100.0%) | 354.3K +354.3K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.001 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 62 | SCHONFELD STRATEGIC ADVISORS LLC | 4.2K +4.2K (+100.0%) | 347.2K +347.2K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.002 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 63 | MORGAN STANLEY | 3.6K +3.6K (+100.0%) | 294.5K +294.5K (+100.0%) | 0.01% +0.008 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 64 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 2.8K +2.8K (+100.0%) | 230.2K +230.2K (+100.0%) | 0.01% +0.006 pp | 0.06% +0.056 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 65 | RENAISSANCE CAPITAL LLC | 2.5K +2.5K (+100.0%) | 200.8K +200.8K (+100.0%) | 0.01% +0.006 pp | 0.14% +0.145 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 66 | SMARTLEAF ASSET MANAGEMENT LLC | 940.00 +940.0 (+100.0%) | 80.0K +80.0K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.003 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 67 | WELLS FARGO & COMPANY/MN | 933.00 +933.0 (+100.0%) | 76.4K +76.4K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 68 | FMR LLC | 700.00 +700.0 (+100.0%) | 57.3K +57.3K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 69 | RIVERPARK ADVISORS, LLC | 463.00 +463.0 (+100.0%) | 37.9K +37.9K (+100.0%) | 0.00% +0.001 pp | 0.01% +0.011 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 70 | ADVISOR GROUP HOLDINGS, INC. | 310.00 +310.0 (+100.0%) | 25.4K +25.4K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 71 | ROSSBY FINANCIAL, LCC | 300.00 +300.0 (+100.0%) | 24.6K +24.6K (+100.0%) | 0.00% +0.001 pp | 0.01% +0.008 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 72 | PARALLEL ADVISORS, LLC | 255.00 +255.0 (+100.0%) | 20.9K +20.9K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 73 | LEGAL & GENERAL GROUP PLC | 184.00 +184.0 (+100.0%) | 15.1K +15.1K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 74 | BANK OF AMERICA CORP /DE/ | 146.00 +146.0 (+100.0%) | 11.9K +11.9K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 75 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 100.00 +100.0 (+100.0%) | 8.2K +8.2K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 76 | QUARRY LP | 83.00 +83.0 (+100.0%) | 6.8K +6.8K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD81.83 +0.0% | 1 qtrs NEW |
| 77 | SBI SECURITIES CO., LTD. | 71.00 +71.0 (+100.0%) | 5.8K +5.8K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.83 +0.0% | 1 qtrs NEW |
| 78 | TOWER RESEARCH CAPITAL LLC (TRC) | 71.00 +71.0 (+100.0%) | 5.8K +5.8K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.83 +0.0% | 1 qtrs NEW |
| 79 | COLONIAL TRUST ADVISORS | 50.00 +50.0 (+100.0%) | 4.1K +4.1K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.84 +0.0% | 1 qtrs NEW |
| 80 | MCF ADVISORS LLC | 39.00 +39.0 (+100.0%) | 3.2K +3.2K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.82 +0.0% | 1 qtrs NEW |
| 81 | ASTER CAPITAL MANAGEMENT (DIFC) LTD | 36.00 +36.0 (+100.0%) | 2.9K +2.9K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD81.83 +0.0% | 1 qtrs NEW |
| 82 | BELL INVESTMENT ADVISORS, INC | 29.00 +29.0 (+100.0%) | 2.4K +2.4K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.83 +0.0% | 1 qtrs NEW |
| 83 | PHYSICIAN WEALTH ADVISORS, INC. | 17.00 +17.0 (+100.0%) | 1.4K +1.4K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.82 +0.0% | 1 qtrs NEW |
| 84 | FRAZIER FINANCIAL ADVISORS, LLC | 14.00 +14.0 (+100.0%) | 1.1K +1.1K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD81.79 +0.1% | 1 qtrs NEW |
| 85 | JONES FINANCIAL COMPANIES LLLP | 12.00 +12.0 (+100.0%) | 982.00 +982.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.83 +0.0% | 1 qtrs NEW |
| 86 | GAMMA INVESTING LLC | 3.00 +3.0 (+100.0%) | 246.00 +246.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.67 +0.2% | 1 qtrs NEW |
| 87 | DV TRADING LLC | 1.00 +1.0 (+100.0%) | 82.00 +82.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.00 +1.0% | 1 qtrs NEW |
| 88 | CITIGROUP INC | 1.00 +1.0 (+100.0%) | 82.00 +82.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD81.00 +1.0% | 1 qtrs NEW |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
25.8K
Shares Outstanding
46.00M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Oguzhan Atay | Co-Founder, Chairman & Chief Executive Officer | 518.4K | — |
| David Tsao | Co-Founder, President, Chief Technology Officer & Director | 460.8K | — |
| Ross Taylor Jr. | Chief Financial Officer | 450.7K | male |
| John D. Lister | Chief Administrative Officer | 441.5K | male |
| Nancy Johnson | Senior Vice President of Sales & Commercial Operations | 406.8K | female |
| John ten Bosch FACMG | Senior Vice President of Laboratory Operations | — | — |
| Judy Wong | VP & Controller | — | female |
| Shan Riku Sakakibara | Chief Product Officer | — | female |
| Thomas Lynch | Chief Compliance Officer, General Counsel & Secretary | — | male |
| Brent Kirk | Vice President of Sales Strategy & Operations | — | male |
| Vaghar Haghiri | Senior Director of People Operations | — | male |
| Gary Palmer | Chief Medical Officer of Oncology | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BLLN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
